News

Leo Pharma, AstraZeneca and Daiichi Sankyo have been named in advertisements for bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Q&As from the social media webinar ran by the PMCPA earlier this year are now published

Changes to PMCPA Case Reports

Vacancies for independent members of the Code of Practice Appeal Board

New PMCPA Managers - Helen Darracott and Ciara O’Brien

Making a complaint form outage/issue

New Senior Appointments at the PMCPA

Novo Nordisk, Daiichi-Sankyo, Lundbeck, AstraZeneca, UCB and Biogen named in advertisements for breaches of the ABPI Code

PMCPA Advice - The provision of Adverse Event Reporting statements in relation to digital materials

Vacancy Manager, PMCPA (12 Month FTC)

Vacancies for independent members of the Code of Practice Appeal Board

New PMCPA Manager - Maleeha Sultan